Novartis Ups Forecast on Lack of Diovan Competitor

July 17 (Bloomberg) -- Novartis AG raised its full-year forecast as generic competition for the Diovan blood-pressure drug failed to materialize in the U.S. Sam Fazeli reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
If Greece Leaves, U.K. Will Follow: Mills
19:50 - JML Founder John Mills, who is funding Business for Britain, the group campaigning for a referendum on leaving the bloc, told Francine Lacqua on “On The Move” that British voters may be influenced by Greece’s decision on leaving the EU. Details of a timetable for the U.K.’s referendum on EU membership is to be outlined in the Queen’s speech on Wednesday.
  • Greece's Exit From Euro Area Is 'Inevitable': Burgess
  • Slots Guarantee Won Irish Backing for IAG Bid: Donohoe
  • How Did IAG Secure Ireland’s Aer Lingus Approval?